| CAS ID: | 1413431-07-8 |
| Molecular Formula: | C24H28N2O3 |
| Molecular Weight: | 401.6 g/mol |
| Monoisotopic Mass: | 401.266 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | |
| Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
| ClinicalTrial ID | NCT02951182 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | November 1, 2016 | Last Verified | August 15, 2018 |
| Sponsor | Vertex Pharmaceuticals Incorporated | ||
Trial Record 2
| ClinicalTrial ID | NCT02971839 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Terminated |
| First Received | November 23, 2016 | Last Verified | August 15, 2018 |
| Sponsor | Vertex Pharmaceuticals Incorporated | ||
| PubChem: | 71470491 |
| ChEMBL: |